Nitric oxide and histone deacetylases a new relationship between old molecules

Communicative and Integrative Biology

Volumn 2, Issue 1, 2009, Pages 11-13

  D Watson, P Marc ^a,b   Riccio, Antonella ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Medlmmune Ltd   (United Kingdom)

Author keywords

Histone deacetylase; Neurodegeneration; Neurons; Nitric oxide; S nitrosylation

Indexed keywords

MAMMALIA;

EID: 60949095770     PISSN: None     EISSN: 19420889     Source Type: Journal    
DOI: 10.4161/cib.2.1.7301     Document Type: Article

References (26)

1. Nott A, Watson PM, Robinson JD, Crepaidi L, Riccio A. S-Nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nature 2008; 455:411-5.
2. Riccio A, Alvania RS, Lonze BE, Ranianan N, Kim T, Huang Y, et al. A nitric oxide signaling pathway controls CREB-mediated gene expression in neurons. Mol Cell 2006; 21:283-94.
3. Gregoretti IV, Lee YM, Goodson HV. Molecular evolution of the histone deacetvlase family: functional implications of phvlogenetic analysis. J Mol Biol 2004; 338:17-31.
4. Yang XJ, Seto E. The Rpd3/Hdal family of lysine deacetylases: from bacteria and yeast to mice and men Nature Rev 2008; 9:206 18.
5. Kazantsev AG, Thompson LM. Therapeutic application of histone deacetvlase inhibitors for central nervous system disorders. Nat Rev Drug Discov 2008; 7:854-68.
6. Hahnen E, Hauke J, Trankle C, Eyupoglu IY, Wirth B, Blumcke I. Histone deacetvlase inhibitors: possible implications for neurodegenerative disorders. Expert Opin Investig Drugs 2008; 17:169-84.
7. Abel T. Zukin RS. Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr Opin Pharmacol 2008; 8:57-64.
8. Mottet D, Castronovo V. Histone deacetylases: target enzymes for cancer therapy. Clin Exp Metastasis 2008; 25:183-9.
9. Glozak MA, Seto E. Histone deacetylases and cancer. Oncogene 2007; 26:5420-32.
10. Berry JM, Cao DJ, Rothermel BA, Hill JA. Histone deacetvlase inhibition in the treatment of heart disease. Expert Opin Drug Saf 2008; 7:53-67.
11. Barnes PJ. Role of HDAC2 in the pathophysiology of COPD. Ann Rev Physiol 2008; In press. doi:10.1 146/annurev.physiol.010908.163257.
12. Glozak MA, Sengupta N, Zhang X, Seto E. Acetylation and deacetylation of non-histone proieins. Gene 2005; 363:15-23.
13. Carey N, La Thangue NB. Histone deacetvlase inhibitors: Gathering pace. Curr Op Pharmacol 2006;6:369-75.
14. Yang XJ, Seto E. Lysine acetylation: codified crosstalk with other posttranslational modifications. Molecular cell 2008; 31:449-61.
15. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 2003; 370:737-49.
16. Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J 2007;404:1-13.
17. Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 2007; 8:766-75.
18. Garthwaite J. Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci 2008; 27:2783-802.
19. Ito K, Hanazawa T, Tomita K, Barnes PJ, Adcock IM. Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Biophys Res Comm 2004; 315:240-5.
20. Valenzuela-Fernandez A, Cabrero JR, Serrador JM, Sanchez-Madrid F. HDAC6: a kev regulator of cvtoskeleton, cell migration and cell-cell interactions. Trends Cell Biol 2008; 18:291-7.
21. Sadoul K, Boyault C, Pabion M, Khochbin S. Regulation of protein turnover bv acetvltransferases and deacetylases. Biochimie 2008; 90:306-12.
22. Boyault C, Sadoul K, Pabion M, Khochbin S. HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination. Oncogene 2007; 26:5468-76.
23. Walkinshaw DR.Tahmasebi S, Bertos NR, Yang XJ. Histone deacetylases as transducers and targets of nuclear signaling. J Cell Biochem 2008; 104:1541-52.
24. Sengupta N, Seto E. Regulation of histone deacetylase activities. J Cell Biochem 2004; 93:57-67.
25. Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS. Protein S-nitrosvlation: purview and parameters. Nature Rev 2005; 6:150-66.
26. Wegener D, Wirsching F, Riester D, Schwienhorst A. A fluorogenic histone deacetylase assay well suited for high-throughput activity screening. Chem Biol 2003; 10:61-8.